Patents by Inventor Anne WIJKHUISEN

Anne WIJKHUISEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-LILRB ANTIBODIES AND USES THEREOF
    Publication number: 20230382991
    Abstract: An antagonist antibody, or an antigen binding fragment thereof, binds both to human and macaque LILRB1 and/or LILRB2, and has diagnostic and therapeutic uses.
    Type: Application
    Filed: October 12, 2021
    Publication date: November 30, 2023
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, UNIVERSITE PARIS SACLAY, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Benoit FAVIER, Sixtine COINDRE, Anne WIJKHUISEN, Stéphanie SIMON, Roger LE GRAND, Olivier LAMBOTTE
  • Method for obtaining antigen-specific human antibodies by in vitro immunisation
    Patent number: 9816072
    Abstract: A method for the in vitro immunization of human B lymphocytes, comprising culturing a total mononuclear cell population of human peripheral blood in the presence of an antigenic composition comprising at least one antigen covalently bonded to both: (i) a Tat protein or a Tat fragment capable of oligomerization and (ii) a ligand of a surface molecule specific to the antigen presenting cells; a method for producing antigen-specific human antibodies derived from said in vitro immunization method.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: November 14, 2017
    Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Michel Leonetti, Patricia Lamourette, Herve Volland, Alexandra Savatier, Anne Wijkhuisen
  • METHOD FOR OBTAINING ANTIGEN-SPECIFIC HUMAN ANTIBODIES BY IN VITRO IMMUNISATION
    Publication number: 20150299655
    Abstract: A method for the in vitro immunisation of human B lymphocytes, comprising culturing a total mononuclear cell population of human peripheral blood in the presence of an antigenic composition comprising at least one antigen covalently bonded to both: (i) a Tat protein or a Tat fragment capable of oligomerisation and (ii) a ligand of a surface molecule specific to the antigen presenting cells; a method for producing antigen-specific human antibodies derived from said in vitro immunisation method.
    Type: Application
    Filed: November 26, 2013
    Publication date: October 22, 2015
    Inventors: Michel LEONETTI, Patricia LAMOURETTE, Herve VOLLAND, Alexandra SAVATIER, Anne WIJKHUISEN